Having trouble accessing articles? Reset your cache.

Restructuring watch

Restructuring watch

Date Company Staff cuts Cash Yrs cash pre-cut Cash date 1H10 oper loss
7/15/10 Adolor Corp. (NASDAQ:ADLR) 30% to ~80 $62.3 1.73 6/30/10 $18.0
Focusing on two programs: marketed drug Entereg alvimopan, a selective peripherally acting mu opioid receptor antagonist co-promoted in the U.S. for postoperative ileus (POI) with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); and its opioid bowel dysfunction

Read the full 745 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers